-
Think Staples Stink? Think Again
Friday, July 6, 2018 - 11:32am | 532The consumer staples sector, the sixth-largest sector weight in the S&P 500, has been rightfully derided as one of this year's worst-performing groups. The Consumer Staples Select Sector SPDR (NYSE: XLP), the largest exchange traded fund tracking the sector, and other traditional cap-...
-
Morgan Stanley Projects A Strong Q4 At Salesforce
Thursday, February 15, 2018 - 11:41am | 410Cloud computing name salesforce.com, inc. (NYSE: CRM) is likely to report strong fourth-quarter results with sustained demand trickling into its fiscal 2019, according to Morgan Stanley. The company is scheduled to report after the market close Feb. 28. The Analyst Analyst Keith Weiss...
-
Myomo CEO Talks M&A Potential: Ossur, Ottobock 'Have Been Inquisitive In The Past'
Tuesday, December 5, 2017 - 4:36pm | 313Myomo Inc (NYSE: MYO) has caught the gaze of some brazen admirers. Ossur and current partner Ottobock “have been inquisitive in the past” about buyout possibilities, Myomo CEO Paul Gudonis told Benzinga Tuesday at the LD Micro Conference. He posited additional merger potential in Asian...
-
LD Micro Small Cap Conference To Host A Litany Of High-Profile Execs, Investors
Monday, December 4, 2017 - 5:28pm | 857The 10-year anniversary edition of the LD Micro Main Event kicked off Monday, Dec. 4 in Los Angeles, California. The event runs through Thursday. A focus on "many of the most influential companies in the micro-cap space" has helped the LD Micro event win the riotous title "Woodstock...
-
What's Happening In Root9B?
Wednesday, August 23, 2017 - 12:32pm | 482Root9B Holdings Inc (NASDAQ: RTNB) investors have been rattled since Friday morning when the stock halted seven times on circuit breakers. Since then, Nasdaq halted trading twice pending news and, on Wednesday morning, twice on circuit breakers. The nano-cap stock is up 287 percent since Friday....
-
Marcum Conference To Connect Public, Private Micro-Caps With Critical Investors
Thursday, May 18, 2017 - 7:40am | 815Throughout his 20-plus-years with Marcum LLP, an independent auditor of public companies, David Bukzin has played witness to the contraction of the IPO market. As the founding head of Marcum’s SEC Services practice, Bukzin supports entrepreneurial companies that opt to migrate into the public...
-
Exclusive: Orexigen Therapeutics Execs Talk Contrave And The Stock's Roller-Coaster Ride
Tuesday, May 2, 2017 - 12:17pm | 1485Meet Orexigen Therapeutics, Inc. (NASDAQ: OREX), a micro-cap biopharmaceutical company delivering one of the strongest stock market performances of 2017 so far. After losing almost 90 percent of its value over 2016, shares have recuperated more than 80 percent this year. Benzinga recently spoke...
-
Small-Cap Value For A Nominal Fee
Friday, April 21, 2017 - 9:23am | 538Low fees on exchange-traded funds are one of the biggest selling points of this asset class and one of the primary reasons investors are continually ditching higher-fee, under-performing actively managed mutual funds. Lower Fees Attract Assets Even better for investors is that ETF issuers are...
-
Where To Find Value With Small Caps
Tuesday, April 11, 2017 - 12:03pm | 580A concern many investors have when mulling small-cap stocks or related exchange-traded funds is the often high valuations that come with the growth opportunity offered by smaller stocks. Finding value with small-caps has proven potent over time. In fact, long-term data suggest small-cap value funds...
-
A Small-Cap Dividend Darling
Sunday, April 9, 2017 - 11:30am | 517U.S. small-cap stocks are among this year's most notable laggards. Something else that has been widely documented is the outperformance offered by ex-U.S. small-caps, a scenario pertaining to both developed and emerging markets smaller stocks. Speaking of outperformance courtesy of emerging...
-
Exclusive: VBI Vaccines CEO Talks Pipeline, Investor Backing, Hep. B Vaccine Opportunity
Monday, April 3, 2017 - 11:16am | 1001VBI Vaccines Inc. - Ordinary Shares (NASDAQ: VBIV) has emerged as one of the best performing small-cap biotech plays of the year, with shares of the Cambridge, Massachusetts-based company quietly jumping over 75 percent year-to-date. With several new vaccines in the pipeline, analysts believe there...
-
Size Matters With Small-Caps ETFs
Thursday, March 16, 2017 - 2:06pm | 492There are massive sums of money sitting in various small-cap exchange traded funds, but in some cases, investors may not be getting the small-cap purity they signed up. Part of the reason for this could be that there isn't a uniform definition of “small cap,” though widely accepted...
-
BioMarin's Upcoming Catalysts Named By Credit Suisse
Monday, January 23, 2017 - 10:57am | 270BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) shares have historically outperformed during product launches, and Credit Suisse’s Kennen MacKay expects the Brineura launch in Q2:17 and upcoming launches of Vosoritide and PEG-PAL to drive earnings as well as investor interest. MacKay initiated...
-
Viridian Experts Talk Recent Cannabis Industry Deals: M&A, Capital Raises And IPOs
Friday, December 16, 2016 - 9:52am | 1015Viridian Capital Advisors is one of the world’s main financial and strategic advisory firms for the cannabis industry. Benzinga recently had the chance to talk to the company’s founder and president Scott Greiper, and one of its analysts, Harrison Phillips, who shared some insight...
-
Sometimes, Less Is More With Small-Cap Stocks
Monday, December 12, 2016 - 12:40pm | 494Small-cap stocks have been getting plenty of press lately, due in large part to some stellar post-election showings. Many investors and the financial media often focus on the Russell 2000 Index, which to be fair, is one of the most widely followed gauges of smaller stocks in the world. And to be...